Evidence map›Paper›PMID 40610922›Full record

ArticleBMC infectious diseases2025

Genotyping and transmission analysis of Mycobacterium tuberculosis in a pediatric population in Czech Republic and Slovakia.

Simona Mäsiarová, Věra Dvořáková, Michaela Hromádková, Anders Norman, Peter Kunč, Jaroslav Fábry, Jarmila Hnilicová, Igor Porvazník, Ivan Solovič, Erik M Rasmussen and 3 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Simona MäsiarováDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Věra DvořákováNational Institute of Public Health, Prague, Czech Republic.
Michaela HromádkováNational Institute of Public Health, Prague, Czech Republic.
Anders NormanInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
Peter KunčClinic of Pediatric Respiratory Diseases and Tuberculosis, National Institute of Pediatric Tuberculosis and Respiratory Diseases, Dolny Smokovec, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Jaroslav FábryClinic of Pediatric Respiratory Diseases and Tuberculosis, National Institute of Pediatric Tuberculosis and Respiratory Diseases, Dolny Smokovec, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Jarmila HnilicováDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
Igor PorvazníkNational Institute of Tuberculosis Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia.
Ivan SolovičNational Institute of Tuberculosis Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia.
Erik M RasmussenInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
Juraj MokrýDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Karolína Doležalová *Department of Paediatrics of the First Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
Matúš Dohál *Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia. matus.dohal@uniba.sk.

Funding

Agentúra na Podporu Výskumu a Vývoja 18-0084Grant of Ministry of Health, Czech Republic 75010330Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0049/25Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0093/22
6 · The paper itself

Abstract

backgroundTuberculosis remains a global health concern, with rising pediatric and adolescent cases. The advancement of diagnostic strategies is crucial for effective control, with whole-genome sequencing emerging as a promising tool. This study explores using whole-genome sequencing in pediatric Tuberculosis.

methodsMycobacterium tuberculosis isolates from pediatric patients and their contacts were collected between January 2023 and June 2024 in Slovakia and the Czech Republic. The isolates were subjected to WGS to characterize the resistance patterns and transmission.

resultsThe study included 37 patients in total-30 pediatric cases and 7 adult index cases-with a single M. tuberculosis isolate collected per patient. The phylogenetic analysis results revealed that 32 out of 37 (86.5%) isolates belonged to the Euro-American lineage. Five isolates (13.5%) belonged to the East-Asian lineage. Genotypic resistance to at least one drug was confirmed in 6 patients (16%). 24 patients were divided into 9 clusters (65%), leaving 13 unclustered (35%). Moreover, the concordance between the identification of source case by WGS and epidemiological anamnesis was confirmed in 60% of patients.

conclusionsEpidemiological data may not always provide accurate insights into the transmission of TB. Consequently, integrating molecular methods, such as WGS, is essential to enhance the reliability and precision of epidemiological analyses.

Indexed as

Mycobacterium tuberculosisTuberculosisAdolescentAdultChildChild, PreschoolCzech RepublicFemaleGenotypeHumansInfantMalePhylogenySlovakiaWhole Genome SequencingDrug resistancePediatric patients, tuberculosisTransmission chainsWhole-genome sequencing

Identifiers

PMID40610922
PMCPMC12225057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.